After yielding positive results during pre-clinical testing, it’s time to prepare for a move into clinical trials. However, there are a few items to consider that can set your study up for success. CRO selection involves much more than an assessment of their service offering. Indication experiences, familiarity with drug delivery mechanisms, and tangential laboratory support represent only a few of the important upfront criteria for developing your shortlist of potential partners.
The article below, published on PharmaLive, covers:
For deeper insights into finding the right partner and developing a successful relationship, click here.
Frances Murphy is a leading authority in clinical CROs, focused on client services and regional growth implementation. Murphy is a dedicated proponent of harnessing truly personalized medicine to develop more effective treatments for patients and brings a high ethical standard to discussions and values transparency and collaboration.
Michael Towse is a dedicated communication specialist with a 20-year background spanning development across a diverse range of CRO environments; from business development to training. His diverse career includes working through the development of communication material, the delivery of communication and initiatives, and time spent on the strategic alignment of sales and marketing strategies to corporate objectives and those objectives central to motivating staff, building teams, and driving business forward.
Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.
